vs
Kennedy-Wilson Holdings, Inc.（KW）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Kennedy-Wilson Holdings, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍（$120.6M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 48.1%，领先335.9%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -11.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -6.0%）
肯尼迪-威尔逊控股是一家房地产投资企业，公司总部位于美国加利福尼亚州比弗利山庄，业务覆盖全球多地房地产领域的投资与运营相关业务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
KW vs RIGL — 直观对比
营收规模更大
KW
是对方的1.7倍
$69.8M
营收增速更快
RIGL
高出32.2%
-11.0%
净利率更高
RIGL
高出335.9%
48.1%
两年增速更快
RIGL
近两年复合增速
-6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.6M | $69.8M |
| 净利润 | $58.0M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 57.3% | 33.2% |
| 净利率 | 48.1% | 384.0% |
| 营收同比 | -11.0% | 21.2% |
| 净利润同比 | 32.7% | 1769.2% |
| 每股收益（稀释后） | $0.22 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KWRIGL
| Q4 25 | $120.6M | $69.8M | ||
| Q3 25 | $116.4M | $69.5M | ||
| Q2 25 | $135.7M | $101.7M | ||
| Q1 25 | $128.3M | $53.3M | ||
| Q4 24 | $135.5M | $57.6M | ||
| Q3 24 | $127.5M | $55.3M | ||
| Q2 24 | $132.0M | $36.8M | ||
| Q1 24 | $136.4M | $29.5M |
净利润KWRIGL
| Q4 25 | $58.0M | $268.1M | ||
| Q3 25 | $-10.2M | $27.9M | ||
| Q2 25 | $5.6M | $59.6M | ||
| Q1 25 | $-29.6M | $11.4M | ||
| Q4 24 | $43.7M | $14.3M | ||
| Q3 24 | $-66.8M | $12.4M | ||
| Q2 24 | $-48.3M | $-1.0M | ||
| Q1 24 | $37.7M | $-8.2M |
毛利率KWRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率KWRIGL
| Q4 25 | 57.3% | 33.2% | ||
| Q3 25 | -6.2% | 40.9% | ||
| Q2 25 | 7.4% | 60.1% | ||
| Q1 25 | -26.9% | 23.9% | ||
| Q4 24 | 36.7% | 28.9% | ||
| Q3 24 | -60.8% | 25.4% | ||
| Q2 24 | -45.5% | 1.2% | ||
| Q1 24 | 47.2% | -23.6% |
净利率KWRIGL
| Q4 25 | 48.1% | 384.0% | ||
| Q3 25 | -8.8% | 40.2% | ||
| Q2 25 | 4.1% | 58.6% | ||
| Q1 25 | -23.1% | 21.5% | ||
| Q4 24 | 32.3% | 24.9% | ||
| Q3 24 | -52.4% | 22.5% | ||
| Q2 24 | -36.6% | -2.8% | ||
| Q1 24 | 27.6% | -27.9% |
每股收益（稀释后）KWRIGL
| Q4 25 | $0.22 | $14.11 | ||
| Q3 25 | $-0.15 | $1.46 | ||
| Q2 25 | $-0.05 | $3.28 | ||
| Q1 25 | $-0.30 | $0.63 | ||
| Q4 24 | $0.24 | $0.82 | ||
| Q3 24 | $-0.56 | $0.70 | ||
| Q2 24 | $-0.43 | $-0.06 | ||
| Q1 24 | $0.19 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $184.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $1.5B | $391.5M |
| 总资产 | $6.6B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资KWRIGL
| Q4 25 | $184.5M | $155.0M | ||
| Q3 25 | $382.6M | $137.1M | ||
| Q2 25 | $309.1M | $108.4M | ||
| Q1 25 | $356.6M | $77.1M | ||
| Q4 24 | $217.5M | $77.3M | ||
| Q3 24 | $367.1M | $61.1M | ||
| Q2 24 | $366.5M | $49.1M | ||
| Q1 24 | $541.9M | $49.5M |
总债务KWRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益KWRIGL
| Q4 25 | $1.5B | $391.5M | ||
| Q3 25 | $1.5B | $117.6M | ||
| Q2 25 | $1.6B | $81.9M | ||
| Q1 25 | $1.6B | $18.6M | ||
| Q4 24 | $1.6B | $3.3M | ||
| Q3 24 | $1.6B | $-14.6M | ||
| Q2 24 | $1.7B | $-29.9M | ||
| Q1 24 | $1.7B | $-31.7M |
总资产KWRIGL
| Q4 25 | $6.6B | $513.6M | ||
| Q3 25 | $6.7B | $242.5M | ||
| Q2 25 | $6.8B | $206.7M | ||
| Q1 25 | $7.2B | $176.0M | ||
| Q4 24 | $7.0B | $164.0M | ||
| Q3 24 | $7.4B | $139.4M | ||
| Q2 24 | $7.5B | $128.4M | ||
| Q1 24 | $7.7B | $126.5M |
负债/权益比KWRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-55.2M | — |
| 自由现金流率自由现金流/营收 | -45.8% | — |
| 资本支出强度资本支出/营收 | 55.2% | — |
| 现金转化率经营现金流/净利润 | 0.20× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-103.5M | — |
8季度趋势，按日历期对齐
经营现金流KWRIGL
| Q4 25 | $11.4M | $22.0M | ||
| Q3 25 | $-7.6M | $24.0M | ||
| Q2 25 | $42.0M | $30.5M | ||
| Q1 25 | $-51.9M | $-893.0K | ||
| Q4 24 | $55.1M | $14.5M | ||
| Q3 24 | $-5.6M | $21.7M | ||
| Q2 24 | $36.7M | $302.0K | ||
| Q1 24 | $-5.6M | $-5.0M |
自由现金流KWRIGL
| Q4 25 | $-55.2M | — | ||
| Q3 25 | $-18.0M | — | ||
| Q2 25 | $29.4M | — | ||
| Q1 25 | $-59.7M | — | ||
| Q4 24 | $-76.5M | — | ||
| Q3 24 | $-27.7M | — | ||
| Q2 24 | $-500.0K | — | ||
| Q1 24 | $-57.1M | — |
自由现金流率KWRIGL
| Q4 25 | -45.8% | — | ||
| Q3 25 | -15.5% | — | ||
| Q2 25 | 21.7% | — | ||
| Q1 25 | -46.5% | — | ||
| Q4 24 | -56.5% | — | ||
| Q3 24 | -21.7% | — | ||
| Q2 24 | -0.4% | — | ||
| Q1 24 | -41.9% | — |
资本支出强度KWRIGL
| Q4 25 | 55.2% | — | ||
| Q3 25 | 8.9% | — | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 97.1% | — | ||
| Q3 24 | 17.3% | — | ||
| Q2 24 | 28.2% | — | ||
| Q1 24 | 37.8% | — |
现金转化率KWRIGL
| Q4 25 | 0.20× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 7.50× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 1.26× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KW
| Consolidated Portfolio Segment | $84.9M | 70% |
| Investment Management Fees | $30.4M | 25% |
| Real Estate | $5.1M | 4% |
RIGL
暂无分部数据
